FORTRESS BIOTECHPRFA Earnings Estimate
FORTRESS BIOTECHPRFA Earnings per Share Projection vs Actual
About FORTRESS BIOTECHPRFA Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of FORTRESS BIOTECHPRFA earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current FORTRESS BIOTECHPRFA estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as FORTRESS BIOTECHPRFA fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Other Information on Investing in FORTRESS Stock
FORTRESS BIOTECHPRFA financial ratios help investors to determine whether FORTRESS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FORTRESS with respect to the benefits of owning FORTRESS BIOTECHPRFA security.